These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Identification of mutations in human apolipoprotein(a) kringle 4-37 from the study of the DNA of peripheral blood lymphocytes: relevance to the role of lipoprotein(a) in atherothrombosis. Scanu AM Am J Cardiol; 1995 Feb; 75(6):58B-61B. PubMed ID: 7863976 [TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein(a) and Apo-A isoforms in patients with intermittent claudication]. Britareva VV; Afanas'eva OI; Dobrovol'skiĭ AB; Ezhov MV; Titaeva EV; Karpov IuA; Pokrovskiĭ SN Ter Arkh; 2002; 74(12):49-52. PubMed ID: 12577841 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a): a new independent risk factor for atherosclerosis. Fulcher G Aust N Z J Med; 1992 Aug; 22(4):326-8. PubMed ID: 1445018 [No Abstract] [Full Text] [Related]
12. [Apolipoproteins in atherosclerosis]. Carino C; Rauseo R; Tiboni GM; De Martiis M Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762 [No Abstract] [Full Text] [Related]
13. [The significance of lipoprotein(a) in assessment of risk for atherosclerosis]. Kullich W; Machreich K Wien Med Wochenschr; 1994; 144(17):407-11. PubMed ID: 7839688 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein (a): where does the atherogenicity reside? Berglund L J Lab Clin Med; 2002 Mar; 139(3):131-2. PubMed ID: 11944022 [No Abstract] [Full Text] [Related]
17. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure. Kimak E; Solski J Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828 [TBL] [Abstract][Full Text] [Related]
18. Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosis. Fievet C; Parra H; Luyeye I; Demarquilly C; Fievet P; Fruchart JC; Bertrand M; Lablanche JM; Drouin P; Gross P Monogr Atheroscler; 1985; 13():134-41. PubMed ID: 3937049 [No Abstract] [Full Text] [Related]
19. [Estrogen-progestin contraception and biohumoral response of new markers of the atheroma risk. Behavior of lipoprotein(a) and apolipoproteins A and B]. Porcelli A; Calleri L; Gallello D; Taccani C; Surico N Minerva Ginecol; 1997 Mar; 49(3):63-6. PubMed ID: 9173339 [TBL] [Abstract][Full Text] [Related]
20. Novel risk factors for atherosclerosis. von Eckardstein A JAMA; 2004 Jan; 291(3):301; author reply 301-2. PubMed ID: 14734585 [No Abstract] [Full Text] [Related] [Next] [New Search]